Bello T R
Sandhill Equine Center, Southern Pines, NC 28387.
Am J Vet Res. 1989 Dec;50(12):2120-3.
Antiparasitic efficacy of ivermectin against migrating Gasterophilus intestinalis was evaluated in 36 treated and 24 nontreated (n = 12) or vehicle-treated (n = 12) ponies experimentally and naturally infected with G intestinalis and naturally infected with G nasalis. Each pony was experimentally infected with 500 G intestinalis 1st instars in 2 divided doses on days -14 and -7 before treatment. On day 0, ivermectin was administered at the rate of 200 micrograms/kg of body weight by IV (n = 12) or IM injection (n = 12) or given as an oral paste (n = 12). Ponies were euthanatized and necropsied 21 days after treatment. In each nontreated or vehicle-treated pony, late 1st-, 1st- to 2nd- instar molt, and early 2nd-instars of G intestinalis were found in the mouth, and 2nd- and 3rd instars of G intestinalis and 3rd instars of G nasalis were found in the stomach. Bots were not found in any ivermectin-treated pony and, thus, ivermectin was 100% effective against oral and gastric stages. Adverse reactions were not observed in ponies given ivermectin by IM injection or orally, but 1 pony given the vehicle IV and 1 pony given ivermectin (in the vehicle) IV had an anaphylactic reaction, resulting in death of the ivermectin-treated pony. It was speculated that the adverse reaction was caused by histamines released in response to vehicle components given by IV injection.
在36匹经治疗以及24匹未治疗(n = 12)或接受赋形剂治疗(n = 12)的小马中,评估了伊维菌素对迁移期肠道胃蝇的抗寄生虫效果。这些小马分别受到肠道胃蝇的实验性和自然感染以及鼻胃蝇的自然感染。在治疗前的第-14天和-7天,每匹小马分两次经实验感染500只肠道胃蝇一龄幼虫。在第0天,伊维菌素通过静脉注射(n = 12)、肌肉注射(n = 12)或制成口服糊剂(n = 12),以200微克/千克体重的剂量给药。治疗21天后对小马实施安乐死并进行尸检。在每匹未治疗或接受赋形剂治疗的小马口中发现了肠道胃蝇的晚期一龄、一龄至二龄蜕皮期和早期二龄幼虫,在胃中发现了肠道胃蝇的二龄和三龄幼虫以及鼻胃蝇的三龄幼虫。在任何接受伊维菌素治疗的小马中均未发现胃蝇,因此,伊维菌素对口腔和胃部阶段的胃蝇100%有效。接受伊维菌素肌肉注射或口服的小马未观察到不良反应,但1匹接受赋形剂静脉注射的小马和1匹接受伊维菌素(溶于赋形剂)静脉注射的小马出现过敏反应,导致接受伊维菌素治疗的小马死亡。据推测,不良反应是由静脉注射赋形剂成分释放的组胺引起的。